Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hyun-Min Ryu"'
Publikováno v:
Composite Interfaces. 30:529-541
Autor:
Hyun-Min Ryu, Deokhoon Kim, Shinkyo Yoon, Ho-Su Lee, Eunjin Lee, Chang Hoon Lee, Wanlim Kim, Seyoung Seo, Kyung Hae Jung, Sook Ryun Park, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Publikováno v:
Cancer Research. 83:424-424
The advent of receptor tyrosine kinase inhibitors (RTKi) are important contributions to treat NSCLC patients harboring genetic aberration effectively. Nevertheless, the emergence of acquired or intrinsic RTKi resistance by other RTK activation bypass
Autor:
Jutta Deckert, Jenny Thirlway, Justyna Mysliwy, Adam Lodge, Yun-Hee Park, Hyun-Min Ryu, Na Ra Han, Ho Young Song, Chul-Woong Chung, Robert J Lutz
Publikováno v:
Blood. 140:3134-3135
Autor:
Wanlim Kim, Sang-We Kim, Eun Kyung Choi, Hannah Yang, Eun Jin Lee, Kang-Seo Park, Deokhoon Kim, Hyun-Min Ryu, Sook Ryun Park, Dae Ho Lee, Kyung Hae Jung, Yujin Jo, Chang-Hoon Lee, Shinkyo Yoon, Seyoung Seo
Publikováno v:
SSRN Electronic Journal.
PurposeHeat shock protein-90 (HSP90) remains an important cancer target because of its involvement in multiple oncogenic protein pathways and biologic processes. Although many HSP90 inhibitors have been tested in the treatment of KRAS-mutant non–sm
Autor:
Jenny Thirlway, Adam Lodge, Daniel J. Williamson, Justyna Mysliwy, Jutta Deckert, Xavier Chauchet, Laura Cons, Yun-Hee Park, Hyun-Min Ryu, Na Ra Han, Ho Young Song, Chul-Woong Chung, Robert J. Lutz
Publikováno v:
Cancer Research. 82:1755-1755
Background: Lymphoma is the most common hematological malignancy with non-Hodgkin B-cell lymphomas (NHL), including those with high unmet clinical need such as relapsed/refractory Diffuse Large B Cell Lymphoma (DLBCL), and Mantle-Cell Lymphoma (MCL),
Autor:
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Publikováno v:
Cancer Research & Treatment; Jul2022, Vol. 54 Issue 3, p767-781, 15p
Autor:
Junyoung, Choi, Hee Jin, Lee, Shinkyo, Yoon, Hyun-Min, Ryu, Eunjin, Lee, Yujin, Jo, Seyoung, Seo, Deokhoon, Kim, Chang Hoon, Lee, Wanlim, Kim, Joo Young, Ha, Soo-Youl, Kim, Gyungyub, Gong, Kyung Hae, Jung, Sook Ryun, Park, Sang-We, Kim, Kang-Seo, Park, Dae Ho, Lee
Publikováno v:
Am J Cancer Res
Anti-PD-1/PD-L1 immunotherapy, as a treatment for many tumors, has shown good efficacy. However, responses to immunotherapy did not always occur or last long., i.e. primary or acquired resistance, even tumors were PD-L1 positive. Several oncogenic pa
Autor:
Hyun Min Ryu, Dong-Eun Lee, Gwan Hui Lee, Gopalan Saianand, Anantha Iyengar Gopalan, Keun-Byoung Yoon
Publikováno v:
Renewable and Sustainable Energy Reviews. 152:111681
This paper presents an efficient and eco-friendly soil stabilization method for binding the soil particles of rammed earth walls. The method uses a combination of a water-soluble acrylic acid–acrylic amide copolymer and an epoxy system containing a
Autor:
Fu Li, Yongwang Li, Lan Zhang, Clarence K. Zhang, Hui-Han A. Hu, Juan Zhang, Ying Pan, Jinwon Jung, Sang Hoon Lee, Hyun-Min Ryu, Yun-Hee Park, Haixiang Yu, Archie N. Tse
Publikováno v:
Molecular Cancer Therapeutics. 20:LBA008-LBA008
ROR1 (receptor tyrosine kinase-like orphan receptor 1) is an oncofetal protein prevalently expressed in a variety of hematological and solid malignancies but largely absent in normal adult tissues, making it an attractive ADC target. CS5001/ABL202/LC